NID2 gene expression is elevated in 9 of 24 cancer types, including GBM, lung adenocarcinoma, colon adenocarcinoma, breast cancer, and renal clear cell carcinoma (p < 0.001, Figure 1D). Here, NID2 is linked to lung adenocarcinoma.